期刊文献+

广东省急性乙型病毒性肝炎影响因素的病例对照研究 被引量:6

Case-control study of determining risk factors of acute hepatitis B in Guangdong Province
原文传递
导出
摘要 目的了解广东省急性乙型病毒性肝炎(乙肝)感染的可能影响因素,为预防控制新发乙肝提供科学依据。方法采用1∶1配对的病例对照研究。选取广东省6个乙肝监测点确诊的新发乙肝患者作为病例,选取同性别、年龄±1岁、HBs Ag和抗-HBs 2项指标同时阴性者作为对照,进行既往肝病史、6个月内输/献血史、医源性接触史、免疫史、生活接触史等问卷调查,对调查结果进行单因素和多因素logistic回归分析。结果 2013年1月至2015年8月广东省6个乙肝监测点共报告确诊急性乙肝病例213例,完成病例对照配对123对,其中男性90对,女性33对;病例组平均年龄为(42.02±18.11)岁,对照组为(42.46±17.98)岁,2组的年龄构成一致(P>0.05)。多因素logistic回归分析显示,乙肝疫苗接种史是急性乙肝感染的保护因素,OR=0.013(95%CI:0.001~0.169);既往肝病史、家庭(宿舍)内有乙肝患者或乙肝病毒携带者、肌肉或静脉注射是急性乙肝感染的危险因素,OR值分别为152.144(95%CI:11.473~2 017.590)、5.182(95%CI:1.073~25.033)和21.097(95%CI:3.407~130.656)。结论接种乙肝疫苗是急性乙肝感染的保护因素,而既往肝病史、家庭(宿舍)内有乙肝患者或乙肝病毒携带者、肌肉或静脉注射是急性乙肝感染的危险因素。建议高危人群尽早接种乙肝疫苗。 Objective To understand possible factors influencing infection of acute hepatitis B (AHB) in Guangdong Province so as to provide scientific basis for prevention and control of it. Methods A 1:1 matched case-control study was conducted. Patients with newly diagnosed AHB in 6 hepatitis B (HB) surveillance sites in Guangdong Province were selected as the case group and individuals matched by the same gender,age ( + 1 year) ,and with both negative HBsAg and anti-HBs were selected as the controis. Participants were asked to complete a questionnaire about their histories of liver disease, blood transfusion/donation within 6 months,iatrogenic exposure,immunization, and life contact. Univariate and multi- variate logistic regression models were used to analyze the data. Results From January 2013 to August 2015, 213 cases of AHB were reported by six surveillance sites in Guangdong Province. A total of 123 cases-control pairs (90 male pairs and 33 female pairs) were included in the final analysis. The average age was (42.02 ± 18.11 ) years for the cases and (42.46± 17.98 ) years for the controls. Age structures between the two groups were consistent ( P 〉 0.05 ) . Multivariate logistic regression showed that history of HB vaccination ( OR:0. 013,95% CI: 0.001 -0. 169) was a protective factor for AHB,while liver disease history( OR:152. 144,95% CI: 11. 473 -2 017. 590), patients with HB or HB carriers in the family (dormitory) ( OR: 5. 182,95 % CI: 1. 073 - 25. 033 ) and muscle/intravenous injection ( OR : 21. 097,95 % CI:3. 407- 130. 656) were risk factors for AHB. Conclusion HB vaccination was a protective factor for AHB. Liver disease history, HB patients or carriers in the family ( donnitory), and muscle/intravenous injection were risk factors. High-risk groups should be vaccinated with HB vaccines as soon as possible.
作者 梁剑 邵晓萍 郑慧贞 徐新 吴承刚 LIANG Jian SHAO Xiao-ping ZHENG Hui-zhen XU Xin WU Cheng-gang(Guangdong Provincial Center for Disease Control and Prevention, Guangzhou 511430, China)
出处 《华南预防医学》 2017年第1期17-22,共6页 South China Journal of Preventive Medicine
基金 国家科技重大专项(2012ZX10002001)
关键词 肝炎 乙型 病例对照研究 因素分析 统计学 Hepatitis B type Case-control study Factor analysis,statistical
  • 相关文献

参考文献14

二级参考文献129

共引文献137

同被引文献54

引证文献6

二级引证文献13

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部